News
Biohaven Shares Jump 70% After Agreeing to Be Bought by Pfizer in a $11.8B Deal
Shares of migraine drug maker Biohaven soared nearly 70% after agreeing to be acquired by Pfizer for almost $11.6 billion in cash as ...
